IBDEI3EO ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,57266,1,3,0)
;;=3^Bronchitis,Acute
;;^UTILITY(U,$J,358.3,57266,1,4,0)
;;=4^J20.9
;;^UTILITY(U,$J,358.3,57266,2)
;;=^5008195
;;^UTILITY(U,$J,358.3,57267,0)
;;=J42.^^264^2855^4
;;^UTILITY(U,$J,358.3,57267,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57267,1,3,0)
;;=3^Bronchitis,Chronic
;;^UTILITY(U,$J,358.3,57267,1,4,0)
;;=4^J42.
;;^UTILITY(U,$J,358.3,57267,2)
;;=^5008234
;;^UTILITY(U,$J,358.3,57268,0)
;;=J45.909^^264^2855^2
;;^UTILITY(U,$J,358.3,57268,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57268,1,3,0)
;;=3^Asthma,Unspec,Uncomplicated
;;^UTILITY(U,$J,358.3,57268,1,4,0)
;;=4^J45.909
;;^UTILITY(U,$J,358.3,57268,2)
;;=^5008256
;;^UTILITY(U,$J,358.3,57269,0)
;;=J45.902^^264^2855^1
;;^UTILITY(U,$J,358.3,57269,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57269,1,3,0)
;;=3^Asthma,Unspec, w/ Status Asthmaticus
;;^UTILITY(U,$J,358.3,57269,1,4,0)
;;=4^J45.902
;;^UTILITY(U,$J,358.3,57269,2)
;;=^5008255
;;^UTILITY(U,$J,358.3,57270,0)
;;=J61.^^264^2855^15
;;^UTILITY(U,$J,358.3,57270,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57270,1,3,0)
;;=3^Pneumoconiosis d/t Asbest & Oth Min Fibers
;;^UTILITY(U,$J,358.3,57270,1,4,0)
;;=4^J61.
;;^UTILITY(U,$J,358.3,57270,2)
;;=^5008262
;;^UTILITY(U,$J,358.3,57271,0)
;;=R09.1^^264^2855^14
;;^UTILITY(U,$J,358.3,57271,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57271,1,3,0)
;;=3^Pleurisy
;;^UTILITY(U,$J,358.3,57271,1,4,0)
;;=4^R09.1
;;^UTILITY(U,$J,358.3,57271,2)
;;=^95428
;;^UTILITY(U,$J,358.3,57272,0)
;;=J84.10^^264^2855^16
;;^UTILITY(U,$J,358.3,57272,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57272,1,3,0)
;;=3^Pulmonary Fibrosis,Unspec
;;^UTILITY(U,$J,358.3,57272,1,4,0)
;;=4^J84.10
;;^UTILITY(U,$J,358.3,57272,2)
;;=^5008300
;;^UTILITY(U,$J,358.3,57273,0)
;;=R91.1^^264^2855^17
;;^UTILITY(U,$J,358.3,57273,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57273,1,3,0)
;;=3^Pulmonay Nodule,Solitary
;;^UTILITY(U,$J,358.3,57273,1,4,0)
;;=4^R91.1
;;^UTILITY(U,$J,358.3,57273,2)
;;=^5019707
;;^UTILITY(U,$J,358.3,57274,0)
;;=B49.^^264^2856^52
;;^UTILITY(U,$J,358.3,57274,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57274,1,3,0)
;;=3^Mycosis,Unspec
;;^UTILITY(U,$J,358.3,57274,1,4,0)
;;=4^B49.
;;^UTILITY(U,$J,358.3,57274,2)
;;=^5000690
;;^UTILITY(U,$J,358.3,57275,0)
;;=C49.9^^264^2856^51
;;^UTILITY(U,$J,358.3,57275,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57275,1,3,0)
;;=3^Malig Neop Connective & Soft Tissue,Unspec
;;^UTILITY(U,$J,358.3,57275,1,4,0)
;;=4^C49.9
;;^UTILITY(U,$J,358.3,57275,2)
;;=^5001136
;;^UTILITY(U,$J,358.3,57276,0)
;;=E11.9^^264^2856^19
;;^UTILITY(U,$J,358.3,57276,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57276,1,3,0)
;;=3^Diabetes Type 2 w/o Complications
;;^UTILITY(U,$J,358.3,57276,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,57276,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,57277,0)
;;=E10.9^^264^2856^18
;;^UTILITY(U,$J,358.3,57277,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57277,1,3,0)
;;=3^Diabetes Type 1 w/o Complications
;;^UTILITY(U,$J,358.3,57277,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,57277,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,57278,0)
;;=D50.0^^264^2856^48
;;^UTILITY(U,$J,358.3,57278,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57278,1,3,0)
;;=3^Iron Deficiency Anemia d/t Blood Loss
;;^UTILITY(U,$J,358.3,57278,1,4,0)
;;=4^D50.0
;;^UTILITY(U,$J,358.3,57278,2)
;;=^267971
;;^UTILITY(U,$J,358.3,57279,0)
;;=D62.^^264^2856^6
;;^UTILITY(U,$J,358.3,57279,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57279,1,3,0)
;;=3^Acute Posthemorrhagic Anemia
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3EO 3968 printed Nov 22, 2024@17:57:26 Page 2
IBDEI3EO ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,57266,1,3,0)
+2 ;;=3^Bronchitis,Acute
+3 ;;^UTILITY(U,$J,358.3,57266,1,4,0)
+4 ;;=4^J20.9
+5 ;;^UTILITY(U,$J,358.3,57266,2)
+6 ;;=^5008195
+7 ;;^UTILITY(U,$J,358.3,57267,0)
+8 ;;=J42.^^264^2855^4
+9 ;;^UTILITY(U,$J,358.3,57267,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,57267,1,3,0)
+12 ;;=3^Bronchitis,Chronic
+13 ;;^UTILITY(U,$J,358.3,57267,1,4,0)
+14 ;;=4^J42.
+15 ;;^UTILITY(U,$J,358.3,57267,2)
+16 ;;=^5008234
+17 ;;^UTILITY(U,$J,358.3,57268,0)
+18 ;;=J45.909^^264^2855^2
+19 ;;^UTILITY(U,$J,358.3,57268,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,57268,1,3,0)
+22 ;;=3^Asthma,Unspec,Uncomplicated
+23 ;;^UTILITY(U,$J,358.3,57268,1,4,0)
+24 ;;=4^J45.909
+25 ;;^UTILITY(U,$J,358.3,57268,2)
+26 ;;=^5008256
+27 ;;^UTILITY(U,$J,358.3,57269,0)
+28 ;;=J45.902^^264^2855^1
+29 ;;^UTILITY(U,$J,358.3,57269,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,57269,1,3,0)
+32 ;;=3^Asthma,Unspec, w/ Status Asthmaticus
+33 ;;^UTILITY(U,$J,358.3,57269,1,4,0)
+34 ;;=4^J45.902
+35 ;;^UTILITY(U,$J,358.3,57269,2)
+36 ;;=^5008255
+37 ;;^UTILITY(U,$J,358.3,57270,0)
+38 ;;=J61.^^264^2855^15
+39 ;;^UTILITY(U,$J,358.3,57270,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,57270,1,3,0)
+42 ;;=3^Pneumoconiosis d/t Asbest & Oth Min Fibers
+43 ;;^UTILITY(U,$J,358.3,57270,1,4,0)
+44 ;;=4^J61.
+45 ;;^UTILITY(U,$J,358.3,57270,2)
+46 ;;=^5008262
+47 ;;^UTILITY(U,$J,358.3,57271,0)
+48 ;;=R09.1^^264^2855^14
+49 ;;^UTILITY(U,$J,358.3,57271,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,57271,1,3,0)
+52 ;;=3^Pleurisy
+53 ;;^UTILITY(U,$J,358.3,57271,1,4,0)
+54 ;;=4^R09.1
+55 ;;^UTILITY(U,$J,358.3,57271,2)
+56 ;;=^95428
+57 ;;^UTILITY(U,$J,358.3,57272,0)
+58 ;;=J84.10^^264^2855^16
+59 ;;^UTILITY(U,$J,358.3,57272,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,57272,1,3,0)
+62 ;;=3^Pulmonary Fibrosis,Unspec
+63 ;;^UTILITY(U,$J,358.3,57272,1,4,0)
+64 ;;=4^J84.10
+65 ;;^UTILITY(U,$J,358.3,57272,2)
+66 ;;=^5008300
+67 ;;^UTILITY(U,$J,358.3,57273,0)
+68 ;;=R91.1^^264^2855^17
+69 ;;^UTILITY(U,$J,358.3,57273,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,57273,1,3,0)
+72 ;;=3^Pulmonay Nodule,Solitary
+73 ;;^UTILITY(U,$J,358.3,57273,1,4,0)
+74 ;;=4^R91.1
+75 ;;^UTILITY(U,$J,358.3,57273,2)
+76 ;;=^5019707
+77 ;;^UTILITY(U,$J,358.3,57274,0)
+78 ;;=B49.^^264^2856^52
+79 ;;^UTILITY(U,$J,358.3,57274,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,57274,1,3,0)
+82 ;;=3^Mycosis,Unspec
+83 ;;^UTILITY(U,$J,358.3,57274,1,4,0)
+84 ;;=4^B49.
+85 ;;^UTILITY(U,$J,358.3,57274,2)
+86 ;;=^5000690
+87 ;;^UTILITY(U,$J,358.3,57275,0)
+88 ;;=C49.9^^264^2856^51
+89 ;;^UTILITY(U,$J,358.3,57275,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,57275,1,3,0)
+92 ;;=3^Malig Neop Connective & Soft Tissue,Unspec
+93 ;;^UTILITY(U,$J,358.3,57275,1,4,0)
+94 ;;=4^C49.9
+95 ;;^UTILITY(U,$J,358.3,57275,2)
+96 ;;=^5001136
+97 ;;^UTILITY(U,$J,358.3,57276,0)
+98 ;;=E11.9^^264^2856^19
+99 ;;^UTILITY(U,$J,358.3,57276,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,57276,1,3,0)
+102 ;;=3^Diabetes Type 2 w/o Complications
+103 ;;^UTILITY(U,$J,358.3,57276,1,4,0)
+104 ;;=4^E11.9
+105 ;;^UTILITY(U,$J,358.3,57276,2)
+106 ;;=^5002666
+107 ;;^UTILITY(U,$J,358.3,57277,0)
+108 ;;=E10.9^^264^2856^18
+109 ;;^UTILITY(U,$J,358.3,57277,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,57277,1,3,0)
+112 ;;=3^Diabetes Type 1 w/o Complications
+113 ;;^UTILITY(U,$J,358.3,57277,1,4,0)
+114 ;;=4^E10.9
+115 ;;^UTILITY(U,$J,358.3,57277,2)
+116 ;;=^5002626
+117 ;;^UTILITY(U,$J,358.3,57278,0)
+118 ;;=D50.0^^264^2856^48
+119 ;;^UTILITY(U,$J,358.3,57278,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,57278,1,3,0)
+122 ;;=3^Iron Deficiency Anemia d/t Blood Loss
+123 ;;^UTILITY(U,$J,358.3,57278,1,4,0)
+124 ;;=4^D50.0
+125 ;;^UTILITY(U,$J,358.3,57278,2)
+126 ;;=^267971
+127 ;;^UTILITY(U,$J,358.3,57279,0)
+128 ;;=D62.^^264^2856^6
+129 ;;^UTILITY(U,$J,358.3,57279,1,0)
+130 ;;=^358.31IA^4^2
+131 ;;^UTILITY(U,$J,358.3,57279,1,3,0)
+132 ;;=3^Acute Posthemorrhagic Anemia
